ENANTA PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2013 to Q2 2024.
  • Enanta Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$395K, a 109% decline year-over-year.
  • Enanta Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$2.79M, a 165% decline year-over-year.
  • Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $2.82M.
  • Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$433K, a 98.5% increase from 2021.
  • Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$28.6M, a 2588% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.79M -$395K -$4.62M -109% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.83M -$363K -$407K -925% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.23M -$622K -$588K -1729% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $2.82M -$1.41M -$1.46M -2920% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-22
Q2 2023 $4.28M $4.22M +$4.67M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$387K $44K +$44K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$431K -$34K +$2K +5.56% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$433K $50K +$23.1M Jul 1, 2022 Sep 30, 2022 10-K 2023-11-22
Q2 2022 -$23.5M -$447K +$8.94M +95.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$32.4M $0 -$7.11M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$25.3M -$36K +$3.26M +98.9% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 -$28.6M -$23M -$33.7M -315% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-22
Q2 2021 $5.14M -$9.38M -$2.24M -31.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $7.38M $7.11M +$11M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$3.65M -$3.29M -$4.8M -319% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $1.15M $10.7M +$11.2M Jul 1, 2020 Sep 30, 2020 10-K 2020-11-25
Q2 2020 -$10M -$7.14M -$6.28M -725% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$3.77M -$3.92M -$716K -22.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$3.05M $1.5M -$2.23M -59.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$826K -$486K -$8.95M -106% Jul 1, 2019 Sep 30, 2019 10-K 2020-11-25
Q2 2019 $8.12M -$866K -$4.56M -123% Apr 1, 2019 Jun 30, 2019 10-K 2020-11-25
Q1 2019 $12.7M -$3.2M -$8.57M -160% Jan 1, 2019 Mar 31, 2019 10-K 2020-11-25
Q4 2018 $21.3M $3.73M +$86K +2.36% Oct 1, 2018 Dec 31, 2018 10-K 2020-11-25
Q3 2018 $21.2M $8.46M +$26.9M Jul 1, 2018 Sep 30, 2018 10-K 2019-11-27
Q2 2018 -$5.74M $3.69M -$413K -10.1% Apr 1, 2018 Jun 30, 2018 10-K 2019-11-27
Q1 2018 -$5.33M $5.37M +$1.81M +50.6% Jan 1, 2018 Mar 31, 2018 10-K 2019-11-27
Q4 2017 -$7.14M $3.64M +$2.1M +136% Oct 1, 2017 Dec 31, 2017 10-K 2019-11-27
Q3 2017 -$9.24M -$18.4M -$19.3M -2333% Jul 1, 2017 Sep 30, 2017 10-K 2018-11-29
Q2 2017 $10M $4.1M +$4.54M Apr 1, 2017 Jun 30, 2017 10-K 2018-11-29
Q1 2017 $5.5M $3.57M +$5.12M Jan 1, 2017 Mar 31, 2017 10-K 2018-11-29
Q4 2016 $382K $1.54M +$11.3M Oct 1, 2016 Dec 31, 2016 10-K 2018-11-29
Q3 2016 -$10.9M $826K -$803K -49.3% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-11
Q2 2016 -$10.1M -$434K -$862K -201% Apr 1, 2016 Jun 30, 2016 10-K 2017-12-11
Q1 2016 -$9.23M -$1.55M +$18.5M +92.2% Jan 1, 2016 Mar 31, 2016 10-K 2017-12-11
Q4 2015 -$27.7M -$9.73M +$18.8M +65.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-12-11
Q3 2015 -$46.5M $1.63M +$1.58M +3294% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-09
Q2 2015 -$48M $428K -$14.7M -97.2% Apr 1, 2015 Jun 30, 2015 10-K 2016-12-09
Q1 2015 -$33.4M -$20M -$20M Jan 1, 2015 Mar 31, 2015 10-K 2016-12-09
Q4 2014 -$13.3M -$28.5M -$28.5M Oct 1, 2014 Dec 31, 2014 10-K 2016-12-09
Q3 2014 $15.2M $48K Jul 1, 2014 Sep 30, 2014 10-K 2015-12-11
Q2 2014 $15.1M Apr 1, 2014 Jun 30, 2014 10-K 2015-12-11
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.